ema glp-1 vision loss recommendation 2025 Receptor Agonists and risk Meeting highlights from the Pharmacovigilance

This method showed better drug delivery to the brain with fewer side effects than traditional oral or nasal methods, as seen in tests on mice with PD

939946, Oct

Victoza is also approved for reducing the risk of major cardiovascular events (such as heart attack, stroke, or death) in adults with type 2 diabetes with known heart disease

5 However, caution is warranted on consuming these large doses, as excess intake can cause toxicity

Notable are the EMPA-REG OUTCOME trial, which showed a significant reduction in aminotransferases with empagliflozin 47 , and a meta-analysis of ten randomized controlled trials with 573 participants that confirmed the superiority of SGLT2 inhibitors over other antihyperglycemic agents in terms of improvement in hepatic and metabolic parameters 48

Level of evidence In the inpatient setting, the practice of blood glucose monitoring is supported by expert opinion and is classified as a general recommendation